Gregory Daniel oversees and provides strategic direction regarding the Engelberg Center for Health Care Reform’s evidence development and biomedical innovation portfolio. This includes medical product safety surveillance, regulatory science and FDA policy issues, comparative effectiveness research, and biomedical innovation. | View Full Bio
Experience
Current Positions
- Fellow, Economic Studies
- Managing Director for Evidence Development & Innovation, Engelberg Center for Health Care Reform.
Past Positions
Vice President of Government and Academic Research at HealthCore, Inc., a research subsidiary of WellPoint, Inc.
Education
Ph.D., Pharmaceutical Economics, Policy, and Outcomes Research (major), Epidemiology (minor), The University of Arizona
- MPH, Biostatistics
- MS, Pharmaceutical Administration
- BS, Pharmacy, The Ohio State University, Columbus, OH